Support

This event is supported by

Identifying multiple proteins that form a signature are much more powerful and reliable than looking at a single protein at a time.

Achieving this you need to cast a wide net of as, that studies hundred to thousand of proteins simultaneously, in everything from a few to a large number of human samples without losing in specificity or sensibility. This makes it possible to find the key biomarkers that form a “protein signature”. These types of signatures, or biomarker profiles, will enable you to get new insights and a better understanding of biology and pathophysiology. They will help you to find biomarkers for stratifying patients, to identify predictive markers that are able monitor development of disease. They will serve as tools for selecting the optimal therapy to the right patient as well as assessing the safety and efficacy of the treatment.

We at Olink® Proteomics provide these tools with validated protein panels that can identify such profiles and provide the basis for more finely tuned diagnostic tools. Olink Biomarker panels enable rapid, high-throughput analysis with exceptional data quality and minimal consumption of biological samples. Only 1 µl of sample is needed to address 92 biomarkers simultaneously and each panel is sufficient for 96 samples.

All assays are rigorously quality controlled, and our validation data is made freely available on our website (https://www.olink.com/).

Olink Proteomics service suppliers or can choose to let Olink Proteomics in-house experts run their samples for them, using the Olink Proteomics Analysis Service.